Skip to main content
VCbacked
Log inGet Started

Dogwood Therapeutics

Alpharetta, United States

Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

$12.5M raised
Jan 2026
Post-IPO Equity
BiotechnologyHealth CareMobile AppsTherapeutics

Top Investors

CK Life Sciences InternationalWilliam BuchalterRobert Buchalter

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dogwood Therapeutics

How much funding has Dogwood Therapeutics raised?
Dogwood Therapeutics has raised $12.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Who are Dogwood Therapeutics's investors?
Dogwood Therapeutics's investors include CK Life Sciences International, William Buchalter, Robert Buchalter.
Where is Dogwood Therapeutics headquartered?
Dogwood Therapeutics is headquartered in Alpharetta, United States.
What does Dogwood Therapeutics do?
Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.
What stage is Dogwood Therapeutics at?
Dogwood Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dogwood Therapeutics — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/dogwood-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Dogwood Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/dogwood-therapeutics
Wikipedia (cite web)
{{cite web |title=Dogwood Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dogwood-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K